Galectin-3 and peripheral artery disease: a Mendelian randomization study
BackgroundMultiple clinical studies have found a significant correlation between elevated galectin-3 (Gal-3) in circulation and the diagnosis and severity of peripheral arterial disease (PAD). The current study used the Mendelian randomization (MR) technique to evaluate the possible causal relations...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2023.1279396/full |
_version_ | 1827391116057509888 |
---|---|
author | Yang Gou Miao Chen Zhi Zhu Chi Cui |
author_facet | Yang Gou Miao Chen Zhi Zhu Chi Cui |
author_sort | Yang Gou |
collection | DOAJ |
description | BackgroundMultiple clinical studies have found a significant correlation between elevated galectin-3 (Gal-3) in circulation and the diagnosis and severity of peripheral arterial disease (PAD). The current study used the Mendelian randomization (MR) technique to evaluate the possible causal relationship between Gal-3 and PAD.MethodsGenome-wide association study (GWAS) data of Gal-3 and PAD were obtained through the MR-Base platform. Then, using Gal-3 as the exposure and PAD as the outcome, a two-sample MR analysis was performed utilizing several regression techniques, including MR-Egger regression, inverse variance weighted (IVW), weighted median, and weighted mode.ResultsSix single-nucleotide polymorphisms (SNPs) were identified and designated as instrumental variables (IVs) that exhibited significant correlations with Gal-3 (linkage disequilibrium r2 < 0.001; P < 5 × 10−8). Various statistical methods showed that there was an absence of a significant link between Gal-3 and PAD (IVW: odds ratio (OR) = 0.9869, 95% confidence interval (CI) = 0.8792–1.1078, P = 0.8232). In addition, the presence of genetic pleiotropy did impact the putative causal relationship between PAD and Gal-3 (MR-Egger intercept = 0.0099, P = 0.659).ConclusionsThere is no current evidence to establish a causal relationship between the level of Gal-3 in circulation and PAD. |
first_indexed | 2024-03-08T17:06:02Z |
format | Article |
id | doaj.art-880cee07daad414da82573b62a2aa3d9 |
institution | Directory Open Access Journal |
issn | 2297-055X |
language | English |
last_indexed | 2024-03-08T17:06:02Z |
publishDate | 2024-01-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Cardiovascular Medicine |
spelling | doaj.art-880cee07daad414da82573b62a2aa3d92024-01-04T05:07:04ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2024-01-011010.3389/fcvm.2023.12793961279396Galectin-3 and peripheral artery disease: a Mendelian randomization studyYang GouMiao ChenZhi ZhuChi CuiBackgroundMultiple clinical studies have found a significant correlation between elevated galectin-3 (Gal-3) in circulation and the diagnosis and severity of peripheral arterial disease (PAD). The current study used the Mendelian randomization (MR) technique to evaluate the possible causal relationship between Gal-3 and PAD.MethodsGenome-wide association study (GWAS) data of Gal-3 and PAD were obtained through the MR-Base platform. Then, using Gal-3 as the exposure and PAD as the outcome, a two-sample MR analysis was performed utilizing several regression techniques, including MR-Egger regression, inverse variance weighted (IVW), weighted median, and weighted mode.ResultsSix single-nucleotide polymorphisms (SNPs) were identified and designated as instrumental variables (IVs) that exhibited significant correlations with Gal-3 (linkage disequilibrium r2 < 0.001; P < 5 × 10−8). Various statistical methods showed that there was an absence of a significant link between Gal-3 and PAD (IVW: odds ratio (OR) = 0.9869, 95% confidence interval (CI) = 0.8792–1.1078, P = 0.8232). In addition, the presence of genetic pleiotropy did impact the putative causal relationship between PAD and Gal-3 (MR-Egger intercept = 0.0099, P = 0.659).ConclusionsThere is no current evidence to establish a causal relationship between the level of Gal-3 in circulation and PAD.https://www.frontiersin.org/articles/10.3389/fcvm.2023.1279396/fullgalectin-3peripheral artery diseaseMendelian randomizationcausalitySNPs (single-nucleotide polymorphisms) |
spellingShingle | Yang Gou Miao Chen Zhi Zhu Chi Cui Galectin-3 and peripheral artery disease: a Mendelian randomization study Frontiers in Cardiovascular Medicine galectin-3 peripheral artery disease Mendelian randomization causality SNPs (single-nucleotide polymorphisms) |
title | Galectin-3 and peripheral artery disease: a Mendelian randomization study |
title_full | Galectin-3 and peripheral artery disease: a Mendelian randomization study |
title_fullStr | Galectin-3 and peripheral artery disease: a Mendelian randomization study |
title_full_unstemmed | Galectin-3 and peripheral artery disease: a Mendelian randomization study |
title_short | Galectin-3 and peripheral artery disease: a Mendelian randomization study |
title_sort | galectin 3 and peripheral artery disease a mendelian randomization study |
topic | galectin-3 peripheral artery disease Mendelian randomization causality SNPs (single-nucleotide polymorphisms) |
url | https://www.frontiersin.org/articles/10.3389/fcvm.2023.1279396/full |
work_keys_str_mv | AT yanggou galectin3andperipheralarterydiseaseamendelianrandomizationstudy AT miaochen galectin3andperipheralarterydiseaseamendelianrandomizationstudy AT zhizhu galectin3andperipheralarterydiseaseamendelianrandomizationstudy AT chicui galectin3andperipheralarterydiseaseamendelianrandomizationstudy |